EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016

Lene Bleich iD, Renate Grohmann, Waldemar Greil iD, Dominik Dabbert, Andreas Erfurth iD, Sermin Toto iD, Johanna Seifert iD

Journal of Neural Transmission · 2024

DOI: 10.1007/s00702-024-02818-7 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neural Transmission, 2024. Verfasst von Lene Bleich und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, 30625, Hannover, Germany. lene.bleich@stud.uni-goettingen.de. Hauptthemen laut MEDLINE: Antipsychotic Agents, Clozapine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinische Hochschule Hannover (MHH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clozapine is a second-generation antipsychotic drug that offers superior treatment results in patients with schizophrenia but is also associated with significant risks. This study analyzes data on pharmacotherapy with clozapine and the associated adverse drug reactions (ADRs) in an inpatient setting including 38,349 patients. Data about the use of clozapine and reports of severe ADRs within the period 1993–2016 were obtained from the multicentered observational pharmacovigilance program “Arzneimittelsicherheit in der Psychiatrie” (AMSP). In total, 586 severe clozapine-associated ADRs were documented (1.53% of all patients exposed). Patients aged ≥65 years had a higher risk of ADRs than patients aged

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsClozapineAdolescentAdultAgedFemaleHumansMaleMiddle AgedYoung AdultAdverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsInpatientsMental DisordersPharmacovigilance

Stichwörter der Autor:innen

AMSP programAdverse drug reactionClozapineDrug safetyPharmacovigilancePsychiatric inpatients

Substanzen

Antipsychotic AgentsClozapine

Autor:innen und Institutionen

  • Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, 30625, Hannover, Germany. lene.bleich@stud.uni-goettingen.de.
  • University Medical Center Göttingen, 37075, Göttingen, Germany. lene.bleich@stud.uni-goettingen.de.
  • Department of Psychiatry and Psychotherapy, LMU University Hospital, 80336, Munich, Germany.
  • Psychiatric Private Hospital, Sanatorium Kilchberg, 8802, Kilchberg, Switzerland.
  • Department of Forensic Psychiatry and Psychotherapy, Klinik Bremen-Ost, 28325, Bremen, Germany.
  • 1st Department of Psychiatry and Psychotherapeutic Medicine, Klinik Hietzing, 1130, Vienna, Austria.

ORCID-Profile: Lene Bleich, Waldemar Greil, Andreas Erfurth, Sermin Toto, Johanna Seifert

Förderung

  • Medizinische Hochschule Hannover (MHH)

Zitieren

APA

Bleich, L., Grohmann, R., Greil, W., Dabbert, D., Erfurth, A., Toto, S., & Seifert, J. (2024). Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016. Journal of Neural Transmission. https://doi.org/10.1007/s00702-024-02818-7

Vancouver

Bleich L, Grohmann R, Greil W, Dabbert D, Erfurth A, Toto S, et al. Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016. Journal of Neural Transmission. 2024. doi:10.1007/s00702-024-02818-7

BibTeX
@article{Bleich2024,
  author = {Bleich, Lene and Grohmann, Renate and Greil, Waldemar and Dabbert, Dominik and Erfurth, Andreas and Toto, Sermin and Seifert, Johanna},
  title = {Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016},
  journal = {Journal of Neural Transmission},
  year = {2024},
  doi = {10.1007/s00702-024-02818-7}
}
Kostenlos starten →